Literature DB >> 29457351

24-hour aortic blood pressure variability showed a stronger association with carotid damage than 24-hour brachial blood pressure variability: The SAFAR study.

Shikai Yu1, Chen Chi1, Athanase D Protogerou2,3, Michel E Safar4, Jacques Blacher4, Antonis A Argyris2,3, Efthimia G Nasothimiou2,3, Petros P Sfikakis2, Theodore G Papaioannou2,3, Henry Xu1, Yi Zhang1, Yawei Xu1.   

Abstract

We aim to compare 24-hour aortic blood pressure variability (BPV) with brachial BPV in relation to carotid damage as estimated by carotid intima-media thickness (CIMT) and cross-sectional area (CCSA). Four hundred and forty five individuals received brachial and aortic 24-hour ambulatory BP monitoring with a validated device (Mobil-O-Graph). Systolic BPV was estimated by average real variability (ARV) and time-weighted standard deviation (wSD). In multiple logistic regression analysis, CIMT > 900 μm was significantly and independently associated with aortic ARV (OR = 1.38; 95% CI: 1.04-1.84), aortic wSD (OR = 1.65; 95% CI: 1.19-2.29) and brachial ARV (OR = 1.53; 95% CI: 1.07-2.18), but not with brachial wSD. CCSA > 90th percentile was significantly and independently associated with aortic ARV (OR = 1.50; 95% CI: 1.07-2.10) and wSD (OR = 1.70; 95% CI: 1.12-2.56), but not with brachial BPVs. In receiver operator characteristics curve analysis, aortic wSD identified CCSA > 90th percentile better than brachial wSD (AUC: 0.73 vs 0.68, P < .01). In conclusion, aortic 24-hour systolic BPV showed a slightly stronger association with carotid damage than brachial BPV. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  average real variability; blood pressure variability; carotid cross-sectional area; intima-media thickness

Mesh:

Year:  2018        PMID: 29457351      PMCID: PMC8030960          DOI: 10.1111/jch.13226

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  35 in total

1.  24-h ambulatory recording of aortic pulse wave velocity and central systolic augmentation: a feasibility study.

Authors:  Leonella Luzardo; Inés Lujambio; Mariana Sottolano; Alicia da Rosa; Lutgarde Thijs; Oscar Noboa; Jan A Staessen; José Boggia
Journal:  Hypertens Res       Date:  2012-05-24       Impact factor: 3.872

2.  Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis.

Authors:  Joseph F Polak; Michael J Pencina; Daniel H O'Leary; Ralph B D'Agostino
Journal:  Stroke       Date:  2011-09-01       Impact factor: 7.914

Review 3.  Blood pressure variability: assessment, predictive value, and potential as a therapeutic target.

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

4.  Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study.

Authors:  D Sander; C Kukla; J Klingelhöfer; K Winbeck; B Conrad
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

5.  Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA).

Authors:  G Mancia; G Parati; M Hennig; B Flatau; S Omboni; F Glavina; B Costa; R Scherz; G Bond; A Zanchetti
Journal:  J Hypertens       Date:  2001-11       Impact factor: 4.844

6.  Prevalence of carotid atherosclerosis in hypertension: preliminary baseline data from the European Lacidipine Study on Atheroscelerosis (ELSA).

Authors:  A Zanchetti
Journal:  Blood Press Suppl       Date:  1996

7.  Left-ventricular hypertrophy is associated better with 24-h aortic pressure than 24-h brachial pressure in hypertensive patients: the SAFAR study.

Authors:  Athanase D Protogerou; Antonis A Argyris; Theodoros G Papaioannou; Georgios E Kollias; Giorgos D Konstantonis; Efthimia Nasothimiou; Apostolos Achimastos; Jacques Blacher; Michel E Safar; Petros P Sfikakis
Journal:  J Hypertens       Date:  2014-09       Impact factor: 4.844

8.  Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects.

Authors:  Alfonso Tatasciore; Giulia Renda; Marco Zimarino; Manola Soccio; Grzegorz Bilo; Gianfranco Parati; Giuseppe Schillaci; Raffaele De Caterina
Journal:  Hypertension       Date:  2007-06-11       Impact factor: 10.190

9.  Ambulatory blood pressure, blood pressure variability and the prevalence of carotid artery alteration: the Ohasama study.

Authors:  Yoriko Shintani; Masahiro Kikuya; Azusa Hara; Takayoshi Ohkubo; Hirohito Metoki; Kei Asayama; Ryusuke Inoue; Taku Obara; Yoko Aono; Takanao Hashimoto; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Hiroshi Satoh; Yutaka Imai
Journal:  J Hypertens       Date:  2007-08       Impact factor: 4.844

Review 10.  Blood Pressure Out of the Office: Its Time Has Finally Come.

Authors:  Lawrence R Krakoff
Journal:  Am J Hypertens       Date:  2015-11-06       Impact factor: 2.689

View more
  3 in total

1.  24-hour aortic blood pressure variability showed a stronger association with carotid damage than 24-hour brachial blood pressure variability: The SAFAR study.

Authors:  Shikai Yu; Chen Chi; Athanase D Protogerou; Michel E Safar; Jacques Blacher; Antonis A Argyris; Efthimia G Nasothimiou; Petros P Sfikakis; Theodore G Papaioannou; Henry Xu; Yi Zhang; Yawei Xu
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-19       Impact factor: 3.738

2.  Central hemodynamics and arterial stiffness by oscillometric pulse-wave analysis in treated Gujarati euglycemic hypertensives: A case-control study.

Authors:  Jayesh D Solanki; Hemant B Mehta; Sunil J Panjwani; Hirava B Munshi; Chinmay J Shah
Journal:  J Family Med Prim Care       Date:  2019-06

Review 3.  Blood pressure and its variability: classic and novel measurement techniques.

Authors:  Aletta E Schutte; Anastasios Kollias; George S Stergiou
Journal:  Nat Rev Cardiol       Date:  2022-04-19       Impact factor: 49.421

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.